| scholarly article | Q13442814 |
| P50 | author | Michael F. Good | Q6830168 |
| Christian R. Engwerda | Q46666275 | ||
| Yana A Wilson | Q60644270 | ||
| Donald P McManus | Q84098959 | ||
| Rachel J Lundie | Q114290902 | ||
| Brendan Crabb | Q16196411 | ||
| Alex Loukas | Q30513842 | ||
| Geoffrey R Hill | Q38327210 | ||
| Ashraful Haque | Q39049681 | ||
| Louise Randall | Q42778974 | ||
| Tania F. de Koning-Ward | Q42798491 | ||
| Mark S. Pearson | Q43109596 | ||
| P2093 | author name string | Amanda C Stanley | |
| Fiona H Amante | |||
| Fabian de Labastida Rivera | |||
| Christian Pieper | |||
| Gladys Yeo | |||
| Alberto Pinzon-Charry | |||
| Mary G Duke | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebral malaria | Q2822915 |
| malaria | Q12156 | ||
| P304 | page(s) | 3632-3642 | |
| P577 | publication date | 2010-08-18 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria | |
| P478 | volume | 185 |
| Q27347602 | Absence of apolipoprotein E protects mice from cerebral malaria |
| Q35654132 | Activated Brain Endothelial Cells Cross-Present Malaria Antigen |
| Q38482862 | Advances in molecular genetic systems in malaria |
| Q34170436 | An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria |
| Q37366984 | Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8(+) T cells |
| Q40225097 | Antecedent Nippostrongylus infection alters the lung immune response to Plasmodium berghei. |
| Q42410932 | Artesunate Exerts a Direct Effect on Endothelial Cell Activation and NF-κB Translocation in a Mechanism Independent of Plasmodium Killing |
| Q37199628 | Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi |
| Q35893711 | Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology. |
| Q37040808 | Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria |
| Q33775493 | CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo |
| Q33873437 | CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. |
| Q35172830 | CD8+ T cells from a novel T cell receptor transgenic mouse induce liver-stage immunity that can be boosted by blood-stage infection in rodent malaria |
| Q40594444 | Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism |
| Q58754437 | Cerebral Malaria in Mouse and Man |
| Q37983138 | Cerebral malaria pathogenesis: revisiting parasite and host contributions. |
| Q26824074 | Cerebral malaria: gamma-interferon redux |
| Q21032533 | Cerebral malaria: mysteries at the blood-brain barrier |
| Q33965057 | Chitinase 3-like 1 is induced by Plasmodium falciparum malaria and predicts outcome of cerebral malaria and severe malarial anaemia in a case-control study of African children |
| Q44843600 | Co-infection with Chikungunya virus alters trafficking of pathogenic CD8(+) T cells into the brain and prevents Plasmodium-induced neuropathology |
| Q35961252 | Consequences of immunopathology for pathogen virulence evolution and public health: malaria as a case study |
| Q38935293 | Controlled release of artemisone for the treatment of experimental cerebral malaria |
| Q37264802 | Cytoadherence of Plasmodium berghei-infected red blood cells to murine brain and lung microvascular endothelial cells in vitro. |
| Q34596034 | Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities |
| Q34776215 | Deficiency of Leishmania phosphoglycans influences the magnitude but does not affect the quality of secondary (memory) anti-Leishmania immunity |
| Q41463619 | Deletion of carboxypeptidase N delays onset of experimental cerebral malaria |
| Q35037323 | Dietary restriction protects against experimental cerebral malaria via leptin modulation and T-cell mTORC1 suppression |
| Q35745551 | Disruption of Parasite hmgb2 Gene Attenuates Plasmodium berghei ANKA Pathogenicity |
| Q36790143 | Early prediction of cerebral malaria by (1)H NMR based metabolomics |
| Q30570570 | Effect of mature blood-stage Plasmodium parasite sequestration on pathogen biomass in mathematical and in vivo models of malaria. |
| Q55322287 | Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria. |
| Q34854215 | Endothelial cells potentiate interferon-γ production in a novel tripartite culture model of human cerebral malaria. |
| Q40558730 | Establishment of a murine model of cerebral malaria in KunMing mice infected with Plasmodium berghei ANKA. |
| Q38689861 | Examining cellular immune responses to inform development of a blood-stage malaria vaccine. |
| Q36100829 | Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria. |
| Q47976889 | Experimental asexual blood stage malaria immunity |
| Q27322655 | Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier |
| Q35907413 | Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection. |
| Q36177513 | Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection |
| Q47850518 | Flt3 ligand treatment modulates parasitemia during infection with rodent malaria parasites via MyD88- and IFN-γ-dependent mechanisms |
| Q34221466 | Formal modeling and analysis of the MAL-associated biological regulatory network: insight into cerebral malaria |
| Q40065863 | Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments. |
| Q56376508 | Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei |
| Q35215354 | Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection |
| Q34931589 | High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology |
| Q44169469 | Host immune evasion strategies of malaria blood stage parasite |
| Q38182192 | Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity? |
| Q36365306 | Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors |
| Q92259289 | Human Microglia Respond to Malaria-Induced Extracellular Vesicles |
| Q36086895 | IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain |
| Q30561036 | Imaging Plasmodium immunobiology in the liver, brain, and lung |
| Q30414192 | Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes. |
| Q34539758 | Inflammatory responses associated with the induction of cerebral malaria: lessons from experimental murine models |
| Q34012443 | Interferons and interferon regulatory factors in malaria |
| Q35175642 | Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis |
| Q35072346 | Malaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen |
| Q35711050 | Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria |
| Q27346458 | Mice rescued from severe malaria are protected against renal injury during a second kidney insult |
| Q36513451 | Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice |
| Q41106752 | Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections. |
| Q41680247 | Myocardial Dysfunction: A Primary Cause of Death Due To Severe Malaria in A Plasmodium falciparum-Infected Humanized Mouse Model |
| Q61448746 | PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8 T Cell Responses |
| Q38378859 | Pathogenic CD8+ T cells in experimental cerebral malaria |
| Q27316972 | Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria |
| Q37817830 | Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy |
| Q40914389 | Physicochemical Aspects of the Plasmodium chabaudi-Infected Erythrocyte |
| Q35822120 | Plasmodium berghei ANKA causes intestinal malaria associated with dysbiosis |
| Q64097654 | Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells |
| Q27005837 | Protection and pathology during parasite infection: IL-10 strikes the balance |
| Q34026083 | Protection from experimental cerebral malaria with a single dose of radiation-attenuated, blood-stage Plasmodium berghei parasites |
| Q40134001 | Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells |
| Q35178181 | Quantitation of brain edema and localisation of aquaporin 4 expression in relation to susceptibility to experimental cerebral malaria. |
| Q27324676 | Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis |
| Q40376689 | Recruited monocytes modulate malaria-induced lung injury through CD36-mediated clearance of sequestered infected erythrocytes. |
| Q37744488 | Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malaria. |
| Q34003170 | Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based β-methasone nanodrug |
| Q30409386 | Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions? |
| Q34058953 | Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection |
| Q34522257 | Sequestration and histopathology in Plasmodium chabaudi malaria are influenced by the immune response in an organ-specific manner |
| Q40146687 | Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes. |
| Q41699908 | Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection |
| Q40916203 | Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria |
| Q36710017 | Systemic release of high mobility group box 1 (HMGB1) protein is associated with severe and fatal Plasmodium falciparum malaria |
| Q52717280 | TCRβ combinatorial immunoreceptor expression by neutrophils correlates with parasite burden and enhanced phagocytosis during a Plasmodium berghei ANKA malaria infection. |
| Q37643882 | Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria |
| Q92091610 | Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties |
| Q35912396 | The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis. |
| Q98665277 | The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation |
| Q26865518 | The Regulation of CD4(+) T Cell Responses during Protozoan Infections |
| Q38666558 | The immunological balance between host and parasite in malaria |
| Q27316120 | The machinery underlying malaria parasite virulence is conserved between rodent and human malaria parasites |
| Q30411019 | Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria |
| Q33685904 | Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity |
| Q47826573 | Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA. |
| Q47982586 | Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection |
| Q27025436 | Vascular dysfunction as a target for adjuvant therapy in cerebral malaria |
| Q40273988 | What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis? |
| Q36618471 | Where have all the parasites gone? Modelling early malaria parasite sequestration dynamics |
Search more.